Takeda Pharmaceutical
346 hedge funds and large institutions have $2.57B invested in Takeda Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 92 increasing their positions, 118 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
346
Holders Change
-43
Holders Change %
-11.05%
% of All Funds
7.53%
Holding in Top 10
7
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-56.25%
% of All Funds
0.15%
New
51
Increased
92
Reduced
118
Closed
86
Calls
$114M
Puts
$97.2M
Net Calls
+$16.4M
Net Calls Change
+$17.5M
Top Buyers
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$56.2M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$23.7M |
| 3 |
D.E. Shaw & Co
New York
|
+$15.7M |
| 4 |
Renaissance Technologies
New York
|
+$13.7M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$12.8M |
Top Sellers
| 1 |
SHCM
Sachem Head Capital Management
New York
|
-$121M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$86M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$85.9M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$44M |
| 5 |
Goldman Sachs
New York
|
-$39.7M |
